Hypothyroxinaemia and thyroid function after preterm birth

Seminars in Neonatology

Volumn 9, Issue 1, 2004, Pages 3-11

  Van Wassenaer, Aleid G ^a   Kok, Joke H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Hypothyroxinaemia; Neurodevelopment; Outcome; Premature infant; Thyroid function; Thyroxine; Triidothyronine

Indexed keywords

IODINE; LIOTHYRONINE; THYROXINE;

BRAIN DEVELOPMENT; CHILD DEVELOPMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG INDICATION; GESTATIONAL AGE; HORMONAL THERAPY; HORMONE ACTION; HUMAN; HYPOTHYROIDISM; HYPOTHYROXINEMIA; NEWBORN SCREENING; NONHUMAN; PERINATAL PERIOD; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; THYROID FUNCTION; THYROID HORMONE METABOLISM; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 1642471680     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(03)00114-3     Document Type: Review

References (52)

1. Chan S, Kachilele S, McCabe CJ et al. Early expression of thyroid hormone deidinases and receptors in human fetal cerebral cortex. Dev Brain Res 2002;138:109-16.
2. Macfaul R, Dorner S, Brett EM et al. Neurological abnormalities in patients treated for hypothyroidism from early life. Arch Dis Child 1978;53:611-9.
3. Becker KB, Stephens KC, Davey JC et al. The type 2 and type 3 iodothyronine deiodinases palsy important roles in coordinating development in Rana catesbeiana tadpoles. Endocrinology 1997;138:2989-97.
4. Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-55.
5. Pop V, Kuipens JL, van Baar AL et al. Low maternal free T4 concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 1999;50:149-55.
6. van Wassenaer AG, Briet JM, van Baar AL et al. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics 2002;109:534-9.
7. Calvo RM, Jauniaux E, Gulbis B et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of fetal development. J Clin Endocrinol Metab 2002;87:1768-77.
8. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neurophysiological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000;85:3975-87.
9. Thorpe-Beeston JG, Nicolaides KH, Felton CV et al. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 1991;324:532-6.
10. Fisher DA, Polk DH, Wu SY. Fetal thyroid metabolism; a pluralistic system. Thyroid 1994;4:367-71.
11. Bates M, St Gernain DL, Galton VA. Expression profiles of the three iodothyronine deiodinases D1, D2 and D3, in the developing rat. Endocrinology 1999;140:844-51.
12. Kamarkar MG, Prabarkaran D, Godbole MM. 5′-Monodeiodinase activity in the developing human cerebral cortex. Am J Clin Nutr 1993;57(Suppl):291S.
13. Fisher DA. Hypothyroxinemia in premature infants: is thyroxine treatment necessary? Thyroid 1999;9:715-20.
14. Santini F, Chiovato L, Ghirri P et al. Serum iodothyronines in the human fetus and the newborn: evidence for an important role of placenta in fetal thyroid hormone homeostasis. J Clin Endocrinol Metab 1999;84:493-8.
15. Richard K, Hume R, Kaptein E et al. Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab 1998;83:2868-74.
16. Fisher DA, Nelson JC, Carlton EI et al. Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid 2000;10:229-34.
17. Uhrmann S, Marks KH, Maisels MJ et al. Thyroid function in the preterm infant: a longitudinal assessment. J Pediatr 1978;92:968-73.
18. van Wassenaer AG, Kok JH, Dekker FW et al. Thyroxine administration to infants less than 30 weeks gestational age decreases plasma triiodothyronine concentrations. Eur J Endocrinol 1998;139:508-15.
19. Adams LM, Emery JR, Clark SJ et al. Reference ranges for newer thyroid function tests in premature infants. J Pediatr 1995;126:122-7.
20. Smith LM, Leake RD, Berman N et al. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. J Perinatol 2000;20:427-31.
21. Clark SJ, Deming DD, Emery JR et al. Reference ranges for thyroid function tests in premature infants beyond the first week of life. J Perinatol 2001;21:531-6.
22. Dembinski J, Arpe V, Kroll M et al. Thyroid function in healthy and sick very-low-birth-weight infants-thyrotropin and free thyroxine levels until the sixth week of age. Biol Neonate 2001;80:210-4.
23. Mercado M, Yu VYM, Francis I et al. Thyroid function in very preterm infants. Early Hum Dev 1988;16:131-41.
24. Rooman RP, Du Caju MVL, Op De Beeck L et al. Low thyroxinaemia occurs in the majority of very preterm newborns. Eur J Pediatr 1996;155:211-5.
25. Vanhole C, Aerssens P, Naulaers G et al. I-Thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res 1997;42:87-92.
26. van Wassenaer AG, Kok JH, Dekker FW et al. Thyroid function in very preterm infants: influences of gestational age and disease. Pediatr Res 1997;42:604-9.
27. Biswas S, Buffery J, Enoch H et al. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome. Pediatrics 2002;109:222-7.
28. Ares S, Escobar-Morreale HF, Quero J et al. Neonatal hypothyroxinemia: effects of iodine intake and premature birth. J Clin Endocrinol Metab 1997;82:1704-12.
29. Ibrahim M, Morreale de Escobar G, Visser TJ et al. Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Arch Dis Child Fetal Neonatal Ed 2003;88:F56-7.
30. Rogahn J, Ryan S, Wells J et al. Randomised trial of iodine intake and thyroid status in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000;83:F86-90.
31. van Wassenaer AG, Stulp MR, Vatianpour F et al. The quantity of thyroid hormone in human milk is too low to influence plasma thyroid hormone levels in the very preterm infant. Clin Endocrinol 2002;56:621-7.
32. Vincent MA, Rodd C, Dussault JH et al. Very low birth weight newborns do not need screening for congenital hypothyroidism. J Pediatr 2002;140:311-4.
33. Rapaport R. Thyroid function in the very low birth weight newborn: rescreen or reevaluate? J Pediatr 2002;140:287-9.
34. Lucas A, Rennie J, Baker BA et al. Low plasma triiodothyronine concentrations and outcome in preterm infants. Arch Dis Child 1988;63:1201-6.
35. Lucas A, Morley R, Fewtrell MS. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 1996;312:1133-4.
36. Meijer WJ, Verloove-Vanhorick SP, Brand R et al. Transient hypothyroxinemia associated with developmental delay in very preterm infants. Arch Dis Child 1992;67:944-7.
37. Den Ouden AL, Kok JH, Verkerk PH et al. The relation between neonatal thyroxine levels and the neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996;39:142-5.
38. Reuss ML, Paneth N, Pinto-Martin JA et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996;334:821-7.
39. Paul DA, Leef KH, Stefano JL et al. Low serum thyroxine on initial newborn screening is associated with intraventricular hemorrhage and death in very low birth weight infants. Pediatrics 1998;101:903-7.
40. Marsh TD, Freeman R, McKeown RE et al. Increased mortality in neonates with low thyroxine values. J Perinatol 1993;7:201-4.
41. Levinton A, Paneth N, Reuss ML et al. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr 1999;134:706-11.
42. Biswas S, Buffery J, Enoch H et al. Pulmonary effects of triiodothyronine and hydrocortisone supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial-thyroid hormone replacement in neonates. Pediatr Res 2003;53:48-56.
43. van Wassenaer AG, Kok JH, de Vijlder JJM et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997;336:21-6.
44. Briet JM, van Wassenaer AG, Dekker FW et al. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001;107:712-8.
45. van Wassenaer AG, Briet JM, van Baar AL et al. Neonatal thyroxine supplementation in very preterm infants: developmental outcome at early school age. Endocrine J 2000;47(Suppl 177):0-285.
46. Kok JH, Briet JM, van Wassenaer AG. Postnatal thyroid hormone replacement in very preterm infants. Semin Perinatol 2001;25:417-25.
47. Ogivy-Stuart A. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed 2002;87:F165-71.
48. Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr 2001;139:182-8.
49. Valerio PG, van Wassenaer AG, Kok JH. A randomized masked study of T4 plus T3 administration in preterms <28 weeks of gestational age: hormonal and clinical effects. Pediatr Res 2002;51:125A.
50. Cools F, van Wassenaer AG, Kok JH et al. Changes in plasma thyroid hormone levels after a single dose of triiodothyronine in premature infants of less than 30 weeks gestational age. Eur J Endocrinol 2000;143:733-7.
51. Clark SJ, Deming DD, Emery JR et al. Reference ranges for thyroid function tests in premature infants beyond the first week of life. J Perinatol 2001;21:531-6.
52. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F et al. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroid ectomized rats. J Clin Invest 1995;96:2828-38.